In this Pharma Manufacturing article, Michalle Adkins, director of life sciences strategy for Emerson’s process systems and solutions business, explains how the built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing.
Latest News
Emerson Announces Support to Educational Programs at the Defence Academy of the United Kingdom
Automation leader provides NI technologies and expertise to educate graduate students on complex test systems
Emerson Releases 2023 Sustainability Report
Global technology and software company Emerson (NYSE: EMR) released its 2023 Sustainability Report today, highlighting the company’s efforts to...
Calvin Butler to Join Emerson’s Board of Directors
Emerson today announced the appointment of Calvin Butler to its Board of Directors, effective August 1, 2024.
